Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинКарта сайта

Поздравляем!
Поздравляем нового Логобуржца surikovaa со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Malaria Transmission Blocking Vaccine Candidate in Iran   Saber Gholizadeh,Navid Dinparast Djadid and Hamid Reza Basseri

Malaria Transmission Blocking Vaccine Candidate in Iran

180 страниц. 2012 год.
LAP Lambert Academic Publishing
More than a century after discovery of malaria transmission by Anopheles mosquitoes, it is still important vector born disease. P. vivax is the main cause of malaria in Iran that transmitted in north and south of Iran by different Anopheline vector species. A large reduction in the burden of malaria has recently been achieved in Iran following the scaling up of effective treatment and vector control programmes. These achievements question the need for a partially effective malaria vaccine targeted at disease prevention. Different genes from several parts of the life cycle of Iranian malaria parasites and their Anopheles vectors are already characterized and also have been challenged or are in challenging process. Ookinete secreted protein, PvWARP, is candidate as malaria Transmission Blocking Vaccines (TBVs). Recently, we have tested the mice raised polyclonal anti-PvWARP in field condition by using Anopheles-Plasmodium model. This is the first study on malaria TBV in the country and...
 
- Генерация страницы: 0.09 секунд -